1. Home
  2. CDRE vs ALVO Comparison

CDRE vs ALVO Comparison

Compare CDRE & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cadre Holdings Inc.

CDRE

Cadre Holdings Inc.

HOLD

Current Price

$34.16

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$4.07

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDRE
ALVO
Founded
2012
2013
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CDRE
ALVO
Price
$34.16
$4.07
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$39.67
$8.00
AVG Volume (30 Days)
398.7K
828.9K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
1.46%
N/A
EPS Growth
13.33
N/A
EPS
0.31
N/A
Revenue
$610,308,000.00
N/A
Revenue This Year
$23.72
$13.28
Revenue Next Year
$6.89
$18.63
P/E Ratio
$109.35
$18.20
Revenue Growth
7.53
N/A
52 Week Low
$25.73
$2.94
52 Week High
$48.76
$9.25

Technical Indicators

Market Signals
Indicator
CDRE
ALVO
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CDRE
ALVO

About CDRE Cadre Holdings Inc.

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments - the Product segment, which is comprised of components that manufacture and sell products, and the Distribution segment, which is comprised of business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: